Insider Transactions in Q3 2022 at Biolife Solutions Inc (BLFS)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 29
2022
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
559
-0.51%
|
$12,857
$23.02 P/Share
|
|
Sep 29
2022
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
463
-0.43%
|
$10,649
$23.02 P/Share
|
|
Sep 29
2022
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
830
-0.23%
|
$19,090
$23.02 P/Share
|
|
Sep 29
2022
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
657
-0.26%
|
$15,111
$23.02 P/Share
|
|
Sep 23
2022
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
569
-1.24%
|
$11,949
$21.91 P/Share
|
|
Sep 01
2022
|
Timothy L. Moore Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,589
+50.0%
|
-
|
|
Aug 31
2022
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
425
-0.17%
|
$9,775
$23.44 P/Share
|
|
Aug 31
2022
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
299
-0.27%
|
$6,877
$23.44 P/Share
|
|
Aug 31
2022
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
906
-0.25%
|
$20,838
$23.44 P/Share
|
|
Aug 31
2022
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
51
-0.11%
|
$1,173
$23.44 P/Share
|
|
Aug 16
2022
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
116
-0.25%
|
$2,784
$24.81 P/Share
|
|
Aug 14
2022
|
Roderick De Greef President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
535
+0.42%
|
-
|
|
Aug 14
2022
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
411
+0.16%
|
-
|
|
Aug 14
2022
|
Karen A. Foster Chief Quality and Operations |
BUY
Grant, award, or other acquisition
|
Direct |
278
+0.25%
|
-
|
|
Aug 14
2022
|
Michael Rice |
BUY
Grant, award, or other acquisition
|
Direct |
504
+0.14%
|
-
|
|
Aug 14
2022
|
Troy Wichterman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
234
+0.51%
|
-
|
|
Aug 10
2022
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
112
-0.04%
|
$2,576
$23.17 P/Share
|
|
Aug 10
2022
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
95
-0.09%
|
$2,185
$23.17 P/Share
|
|
Aug 10
2022
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
42
-0.12%
|
$966
$23.17 P/Share
|
|
Aug 10
2022
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
171
-0.05%
|
$3,933
$23.17 P/Share
|
|
Aug 10
2022
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
52
-0.05%
|
$1,196
$23.17 P/Share
|
|
Aug 10
2022
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
40
-0.12%
|
$920
$23.17 P/Share
|
|
Aug 03
2022
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
4,600
-11.27%
|
$92,000
$20.03 P/Share
|
|
Aug 01
2022
|
Amy Du Ross Director |
BUY
Grant, award, or other acquisition
|
Direct |
295
+1.4%
|
-
|
|
Aug 01
2022
|
Joseph C Schick Director |
BUY
Grant, award, or other acquisition
|
Direct |
311
+1.26%
|
-
|
|
Aug 01
2022
|
Joydeep Goswami Director |
BUY
Grant, award, or other acquisition
|
Direct |
280
+1.48%
|
-
|
|
Aug 01
2022
|
Rachel Ellingson Director |
BUY
Grant, award, or other acquisition
|
Direct |
259
+1.24%
|
-
|
|
Jul 29
2022
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
524
+0.21%
|
-
|
|
Jul 29
2022
|
Karen A. Foster Chief Quality and Operations |
BUY
Grant, award, or other acquisition
|
Direct |
355
+0.32%
|
-
|
|
Jul 29
2022
|
Michael Rice |
BUY
Grant, award, or other acquisition
|
Direct |
643
+0.18%
|
-
|
|
Jul 29
2022
|
Roderick De Greef President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
683
+0.54%
|
-
|
|
Jul 29
2022
|
Troy Wichterman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
299
+0.65%
|
-
|
|
Jul 22
2022
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
367
-0.89%
|
$6,239
$17.94 P/Share
|
|
Jul 22
2022
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
252
-0.77%
|
$4,284
$17.85 P/Share
|
|
Jul 17
2022
|
Roderick De Greef President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
828
+0.66%
|
-
|
|
Jul 17
2022
|
Karen A. Foster Chief Quality and Operations |
BUY
Grant, award, or other acquisition
|
Direct |
430
+0.39%
|
-
|
|
Jul 17
2022
|
Michael Rice |
BUY
Grant, award, or other acquisition
|
Direct |
779
+0.21%
|
-
|
|
Jul 17
2022
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
635
+0.25%
|
-
|
|
Jul 17
2022
|
Troy Wichterman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
362
+0.79%
|
-
|
|
Jul 12
2022
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
9,158
-6.85%
|
$137,370
$15.79 P/Share
|
|
Jul 12
2022
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
254
-0.61%
|
$3,810
$15.79 P/Share
|
|
Jul 03
2022
|
Roderick De Greef President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
900
+0.67%
|
-
|
|
Jul 03
2022
|
Michael Rice |
BUY
Grant, award, or other acquisition
|
Direct |
847
+0.23%
|
-
|
|
Jul 03
2022
|
Troy Wichterman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
394
+0.86%
|
-
|
|
Jul 03
2022
|
Karen A. Foster Chief Quality and Operations |
BUY
Grant, award, or other acquisition
|
Direct |
468
+0.43%
|
-
|
|
Jul 03
2022
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
690
+0.27%
|
-
|
|
Jul 01
2022
|
Joseph C Schick Director |
BUY
Grant, award, or other acquisition
|
Direct |
409
+1.67%
|
-
|
|
Jul 01
2022
|
Rachel Ellingson Director |
BUY
Grant, award, or other acquisition
|
Direct |
341
+1.65%
|
-
|
|
Jul 01
2022
|
Amy Du Ross Director |
BUY
Grant, award, or other acquisition
|
Direct |
389
+1.87%
|
-
|
|
Jul 01
2022
|
Joydeep Goswami Director |
BUY
Grant, award, or other acquisition
|
Direct |
369
+1.97%
|
-
|